IDH1 and astrocytoma (excluding glioblastoma): Therefore, the aim of this study was to characterize the genomic profile of 65 Brazilian astrocytomas, using aCGH and MSI, as well as to associate these data with the mutational status of the TERT promoter and IDH1 genes, and clinico-pathological features of the patients.